Advertisement

Archives of Virology

, Volume 156, Issue 6, pp 1073–1077 | Cite as

Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes

  • Mikako Ito
  • Yuko Katakai
  • Fumiko Ono
  • Hirofumi Akari
  • Ryo-zabro Mukai
  • Tomohiko Takasaki
  • Akira Kotaki
  • Ichiro KuraneEmail author
Brief Report

Abstract

Neutralizing antibody responses were examined in monkeys after dengue virus infections. In monkeys that had been infected once or twice with DENV-2, neutralizing antibody was cross-reactive with all four serotypes after secondary or tertiary infection with DENV-3. In monkeys that had been inoculated with DENV-1 and DENV-2 in the primary and secondary infections, neutralizing antibody titers did not increase after tertiary infection with DENV-3. These results indicate that antibody responses after secondary and tertiary infections with different serotypes are cross-reactive with all four serotypes, consistent with what has been observed in humans, and suggest that monkeys are useful for determining neutralizing antibody responses.

Keywords

Dengue virus Monkey Neutralyzing antibody Serotype cross-reactivity 

Notes

Acknowledgments

Animal procedures were approved by the Committees on Biosafety and Animal Handling and Ethical Regulations of the National Institute of Infectious, Diseases, Japan. This work was supported by the Research on Emerging and Re-emerging Infectious Diseases from Ministry of Health, Labour and Welfare, Japan (H17-Shinkou-019 and H20-Shinkou-ippan-015), and the Research on Biological Resources and Animal Models for Drug Development from Ministry of Health, Labour and Welfare, Japan (H19-Seibutsushigen-ippan-003).

References

  1. 1.
    Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481PubMedCrossRefGoogle Scholar
  2. 2.
    Gubler DJ, Kuno G, Markoff L (2009) Flaviviruses. In: Knipe DM, Howley PM (eds) Fields Virology. Lippincott Williams & Wilkins, New York, pp 1155–1251Google Scholar
  3. 3.
    Ito M, Mukai RZ, Takasaki T, Kotaki A, Kurane I (2010) Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Arch Virol 155:1617–1624PubMedCrossRefGoogle Scholar
  4. 4.
    Kelly EP, Greene JJ, King AD, Innis BL (2000) Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine 18:2549–2559PubMedCrossRefGoogle Scholar
  5. 5.
    Reed LJ, Muench HA (1938) Simple method of estimating fifty percent endpoints. Am J Hyg 27:493–497Google Scholar
  6. 6.
    Innis BL (1997) Antibody responses to dengue virus infection. In: Gubler DJ, Kuno G (eds) Dengue and dengue hemorrhagic fever. Cab International, New York, pp 221–243Google Scholar
  7. 7.
    Chanama C, Anantapreecha S, A-nuegoonpipat A, Sa-gnasang A, Kurane I, Sawanpanyalert P (2004) Analysis of specific IgM responses in secondary dengue virus infections: levels and positive rates in comparison with primary infections. J Clin Virol 31:185–189PubMedCrossRefGoogle Scholar
  8. 8.
    Sa-ngasang A, Anantapreecha S, A-nuegoonpipat A, Chanama S, Wibulwattanakij S, Pattanakul K, Sawanpanyalert P, Kurane I (2006) Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol Infect 134:820–825PubMedCrossRefGoogle Scholar
  9. 9.
    Kochel TJ, Watts DM, Gozalo AS, Ewing DF, Porter KR, Russel KL (2005) Cross-serotype neutralization of dengue virus in Aotus nancymae monkeys. J Infect Dis 191:1000–1004PubMedCrossRefGoogle Scholar
  10. 10.
    Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, Ennis EA, Rothman A, Libraty D (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort of DV infection in Thailand. J infect Dis 189:990–1000PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Mikako Ito
    • 1
  • Yuko Katakai
    • 2
  • Fumiko Ono
    • 2
  • Hirofumi Akari
    • 3
    • 4
  • Ryo-zabro Mukai
    • 2
  • Tomohiko Takasaki
    • 1
  • Akira Kotaki
    • 1
  • Ichiro Kurane
    • 1
    Email author
  1. 1.Department of Virology 1National Institute of Infectious DiseaseTokyoJapan
  2. 2.The Corporation for Production and Research of Laboratory PrimatesTsukubaJapan
  3. 3.Laboratory of Disease Control, Tsukuba Primate Research CenterNational Institute of Biomedical InnovationTsukubaJapan
  4. 4.Section of Comparative Immunology and Microbiology, Center forHuman Evolution Modeling ResearchPrimate Research Institute, Kyoto UniversityInuyamaJapan

Personalised recommendations